Purple Biotech Ltd.

Regulatory Filings • Jul 15, 2020

_________ false

����� ����� ��"�	2 381
KITOV PHARMA LTD
Corporation no: 520031238	12724
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	15/07/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-068047	Time of broadcast: 08:17 08:05:02

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM D Notice of Exempt Offering of Securities KITOV PHARMA LTD. ����� ������ ������ �� ������ ���� "��" ���� ������ �� ����� ��� ����� ���� ������ �� ����� ��� ���� ����"� . ��� �� ���� ����� ���� �� ����� ����� ����� ������ ������ ���� �� ������ ������ ���� �� �����, ��� ����� ����� �� ����� ������ ���� ��� ����� �� ���� �����, �� �� ����, ����� �� ����� ���� ����� ����� ���� ����� ���� ������ �� ���� �������� ����� ����� ������ ��� ��� ����� �� ���� �����

ea124141-d_kitovpharmaltdEDGAR1_isa.pdf

The submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a Form D originally submitted by the Company to the United States Securities Exchange Commission for the purposes of notifying the United States Securities Exchange Commission, as well for purposes of notifying the applicable State(s) of solicitation, of an exempt offering of securities in the United States of America and within such applicable State(s) of solicitation, should not be deemed an admission by the Company that such submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation) 5761-2000, nor an admission by the Company that this submission is necessarily being delivered pursuant to the aforesaid laws and regulations. ����� ������ ����� ���� ������ ����.���� D-
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 23/06/2020
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: info@kitovpharma.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: adim@kitovpharma.com 1
Israel